Risk of oxytocin overdose during labour and childbirth
Cease pre-preparing oxytocin infusions at ward level. Higher postnatal dose accidentally given before birth harms mother and infant.
National Patient Safety Alerts recorded as open for this trust after their completion deadline had passed, drawn from the MHRA Central Alerting System compliance report of 2 September 2026. That report names only organisations past a deadline, so it records neither compliance nor the position since that snapshot.
Cease pre-preparing oxytocin infusions at ward level. Higher postnatal dose accidentally given before birth harms mother and infant.
Data from the MHRA Central Alerting System compliance report of 2 September 2026, which lists alerts that had passed their completion deadline and remained open at that date. The Central Alerting System does not publish a list of compliant organisations, and the report says nothing about the position since that snapshot.